1 Institute for Translational Medicine and Novel Therapeutics, Healthnovations International, Houston, TX, USA ; Department of Primary Care Health Sciences, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK ; National Cancer Institute Alliance for Nanotechnology in Cancer, National Institutes of Health, Bethesda, MD, USA.
2 Institute for Translational Medicine and Novel Therapeutics, Healthnovations International, Houston, TX, USA.
3 Harvard Global Health Institute, Harvard Medical School, Harvard University, Boston, MA, USA.
4 World Bank, WHO International Agency for Research on Cancer, United Nations Development Group, New York, NY, USA.
5 National Cancer Institute Alliance for Nanotechnology in Cancer, National Institutes of Health, Bethesda, MD, USA ; Department of Nanomedicine, Houston Methodist Research Institute, Alliance for NanoHealth, Houston, TX, USA.